scholarly journals Evaluation of the Acute Hepatoprotective Potential of Hydroethanolic Extract of Duranta erecta L. Parts

2020 ◽  
Vol 2020 ◽  
pp. 1-10
Author(s):  
Shadrack Donkor ◽  
Christopher Larbie ◽  
Gustav Komlaga ◽  
Benjamin Obukowho Emikpe

Liver disease is a major health problem and its treatment is costly in most developing countries with attendant adverse effects. This study aimed at determining the acute hepatoprotective efficacy of Duranta erecta hydroethanolic extracts of leaves, ripe and unripe fruits against CCl4-, and acetaminophen-induced hepatotoxicity in animals. Materials and Methods. CCl4 (1 mL/kg body weight in olive oil) and acetaminophen (500 mg/kg b.wt) were used to induce hepatotoxicity in the animals. Animals were treated with extracts at 250 mg/kg b.wt and standard drug, silymarin (100 mg/kg), for 7 days. Hepatoprotective efficacy was assessed by assaying serum biochemical markers such as alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP), gamma-glutamyl transferase (γGT), bilirubin (Bil), antioxidative biomarkers including reduced glutathione (GSH), glutathione peroxidase (GPx), glutathione transferase (GST), superoxide dismutase (SOD), malondialdehyde (MDA), hydrogen peroxidase (H202), and nitric oxide (NO), as well as histological observations. Results. Exposure of the animals to CCl4 and acetaminophen resulted in liver injury as evidenced by elevated ALT, AST, ALP, γGT, Bil, MDA, H2O2, and NO levels with resultant derangement in liver microarchitecture. Pretreatment with hydroethanolic extracts, particularly ripe fruits of Duranta erecta, led to a reduction in these indicators and an increase in GSH, GPx, GST, and SOD levels. Biochemical data were supported by improvement in liver structure. Conclusion. The findings suggest that hydroethanolic Duranta erecta ripe fruits extract possesses hepatoprotective and antioxidative activities against CCl4- and acetaminophen-induced toxicity and could be developed as a potent agent for drug-induced liver diseases.

2018 ◽  
Vol 69 (3) ◽  
pp. 747-751 ◽  
Author(s):  
Daniela Gabriela Badita ◽  
Iulia Ioana Stanescu ◽  
Andra Balcangiu Stroescu ◽  
Dan Piperea Sianu ◽  
Daniela Miricescu ◽  
...  

Viral hepatitis represents a major health problem worldwide. Approximately 1.4 million people are infected with hepatitis A virus every year, although given that most of the cases evolve asymptomatically the real number could be even higher. At the same time, hepatitis B virus affects up to 30% of the world population and represents one of the main causes of cirrhosis and hepatocellular carcinoma. Thus, it is very important to understand the physiopathology of viral hepatitis A and B not only for the diagnosis, but also for the therapeutic protocol. The present research aimed to determine if HAV and HBV can alter serum and salivary levels of total protein and of 2 important electrolytes: calcium and potassium.


2012 ◽  
Vol 1 (1) ◽  
pp. 20-26
Author(s):  
Biswajit Majumdar ◽  
Arun Kumar Sinha ◽  
Shrawan Yadav

Phytochemicals, that is, chemicals present in various plants and herbs , are now becoming important candidates for development of drugs.Wide range of medicinals plants {Plants from which potential photochemicals are isolated for development of drugs for treatment of diseases}present in South Asian countries have now been increasingly utilized for development of phytomedicines. Treatment with ethanol extract of leaf of Cajanus indicus Spreng at a dose of 50 mg /kg body weight for 20 days, after induction of hepatotoxic damage by CCl4, produce significant elevation of the hepatic injury. The liver marker enzymes like(Aspartate Transaminate) AST, GGT(Gamma Glutamyl Transferase), ALT(Alanine Transaminase) and ALP(Alkaline Phosphatase) decreased significantly at the above dose showing the optimum effect against hepatic damage. The liver antioxidant enzymes SOD, catalase, glutathione peroxidase, glutathione reductase and glutathione transferase and the membrane damaging indicators TBARS(Thiobarbituric Acis Reactive Species), conjugate diene and marker of glutathione status indicate the mechanism of healing action to be due to scavenging of free radicals or ROS. The results thus gives a confirmatory proof that the healing action of ethanol extract of leaf of Cajanus indicus Spreng is for shifting of equilibrium from the peroxidant to antioxidant side and the leaf acts as a natural antioxidant and healer of CCl4 induced hepatotoxicity.DOI: http://dx.doi.org/10.3126/jonmc.v1i1.7284 Journal of Nobel Medical College Vol.1(1) 2011 20-26


2007 ◽  
Vol 23 (5-6-2) ◽  
pp. 245-250 ◽  
Author(s):  
A. Dinischiotu ◽  
D. Dinu ◽  
M. Rebedea ◽  
G. Stoian ◽  
I. Taranu ◽  
...  

Thirty-5 weeks-old pigs were fed corn-soybean diets containing 0.5 ppm and 1.5 ppm. deoxynivalenol. Sera samples were collected from ten piglets in each group at the end of 35 days of the trial to study the effect of certain serum biochemical parameters. Highly significant (P < 0.05) differences were observed for serum urea and gamma glutamyl transferase between control and mycotoxin treated groups. Mycotoxin treated groups did not reveal any significant difference for serum total protein, albumin, globulin, aspartate transferase and alanine transferase.


Author(s):  
SOUMENDRA DARBAR ◽  
SRIMOYEE SAHA ◽  
KAUSIKISANKAR PRAMANIK ◽  
ATISKUMAR CHATTOPADHYAY

Objectives: Hepatic dysfunction is a critical public health problem affecting the global population, characterized by excessive deposition of extracellular matrix components due to increased matrix production and decreased matrix degradation. The present work was aimed to evaluate hepatoprotective effect of AKSS16-LIV01 a newly developed multiherbal formulation against carbon tetrachloride (CCl4)-induced liver dysfunction in Swiss albino mice to establish it as a bench to bedside formulation catering to the various facets of hepatic malfunction. Methods: Thirty-six Swiss adult albino Wister mice divided into six groups. Group-I control untreated animals, Group-II received AKSS16-LIV01 (400 mg/kg), Group-III received CCl4 (1 ml/kg-bw), Group-IV received AKSS16-LIV01 (200 mg/kg) after 2 weeks CCl4 induction, Group-V received AKSS16-LIV01 (400 mg/kg) after 2 weeks CCl4 induction, and Group-VI received standard drug silymarin (100 mg/kg). At the end of the experimental period, all the animals were fasted overnight and blood was collected through retro-orbital plexus for preparation of serum and was analyzed for biochemical parameters, lipid profile, and total plasma protein. Liver tissue was collected for histological study. Results: The combined plant extract including six Indian medicinal herbs and three medicinal spices (AKSS16-LIV01) showed significant hepatoprotective effect by controlling the various essential biochemical parameters in serum. Moreover, treatment with AKSS16-LIV01 raised the level of serum total protein, normalizes the serum biochemical and lipid profiles parameters. Pre-treatment with AKSS16-LIV01 in mice also restored the alteration of various liver parameters such as aspartate aminotransferase, alanine aminotransferase, alkaline phosphatase, gamma-glutamyl transferase, blood urea nitrogen, total bilirubin, and direct bilirubin on CCl4-induced liver damage. Gross liver morphology and normal histological examination of the liver also supported hepatic protection by AKSS16-LIV01. Conclusion: Taken together, these results suggest that AKSS16-LIV01 may induce remarkable protective effects against hepatic injury induced by CCl4 treatment.


2021 ◽  
Vol 11 (9) ◽  
pp. 259-264
Author(s):  
Linel Darrel Ngokana ◽  
Fylla Onanga Koumou ◽  
Landry Aymar Loukanou Mbouaka

Objectives: Our goal was to contribute to the production of reference values ​​of plasma or serum biochemical markers by determining the reference values ​​of gamma-glutamyltransferase (GGT), aspartate aminotransferase (ASAT) and alanine aminotransferase (ALAT) in young Congolese presumed to be healthy. Methods: 250 young Congolese presumed to be healthy (125 boys and 125 girls) aged 15 to 25 participated in the study. They were selected according to anamnestic and clinico-biological criteria. Samples were taken on a tube containing EDTA and the resulting plasma was stored at -20 ° C. The KENZA MAX spectrophotometer was used to analyze GGT, ASAT and ALAT. The median and the 2.5-97.5 percentiles were used to set the reference limits for each enzyme. The benchmarks determined were compared with those reported by other Africans, Europeans, Indians and Americans. Results: The established reference values ​​were: GGT 12.15-61.85 IU/L for boys and 7-51.95 IU / l for girls (p˂0.0001); ASAT 21.60-94.85 IU/L for boys and 17-84.85 IU/L for girls (p = 0.0003); ALAT 8.30-74.40 IU/L for boys and 8-53.85 IU/L for girls (p˂0.0001). In addition, the comparison between our values ​​and those of other populations showed significant differences. Conclusion: Our results underline the importance of establishing reference values ​​for plasma enzymes specific to the Congolese population. The use of the values ​​established in the ’other populations could induce errors of judgment by excess or by default. Key words: Gamma-glutamyltransferase, Aspartate aminotransferase, Alanine aminotransferase, Reference values, Congo.


2021 ◽  
Vol 12 (4) ◽  
pp. 5444-5457

This study centered on Zinc oxide nanoparticles capped with Pterocarpus mildbraedii leaf extracts (PmZnONPs) as a potent antioxidant and anti-inflammatory agent against carbon tetrachloride (CCl4) ‐ induced hepatorenal toxicity in rats. PmZnONPs were characterized by Fourier transform infrared spectroscopy (FTIR), Brunauer–Emmett–Teller (BET), scanning electron microscopy (SEM), X-ray diffraction pattern (XRD), and transmission electron microscopy (TEM) techniques. The FTIR results revealed the presence of various functional groups in PmZnONPs, while the BET showed a surface area of 1.55 mg-2. In vitro, PmZnONPS showed comparable 1,1‐diphenyl‐2‐picrylhydrazyl (DPPH), and 2,2′‐azino‐bis(3‐ethylbenzothiazoline‐6‐sulfonic acid (ABTS) radicals scavenging activities as Vitamin C. After that, PmZnONPs (1 and 3 mg/kg) were administered (p.o.) into six groups of rats, using CCl4 as the toxicant. The obtained results demonstrated that PmZnONPS significantly prevented CCl4‐induced elevations of alanine aminotransferase (ALT), aspartate aminotransferase (AST), gamma‐glutamyl transferase (GGT), alkaline phosphatase (ALP), bilirubin (BIL), creatinine, and urea. Moreover, PmZnONPs restored the levels of plasma uric acid, hepatorenal antioxidant enzymes, including superoxide dismutase, glutathione peroxidase, glutathione transferase, and glutathione that were significantly decreased by CCl4 treatment. Immunohistochemical studies showed that PmZnONPs significantly suppressed the high immunoreactivity of nuclear factor kappa B (NF‐κB), cyclooxygenase‐2 (COX-2), and interleukin‐6 (IL-6) arising from CCl4 intoxication. Thus our data hint that PmZnONPs suppressed CCl4‐induced toxicity in the liver and kidney of rats via its combined antioxidant and anti‐inflammatory properties.


2014 ◽  
Vol 44 (12) ◽  
pp. 2236-2244
Author(s):  
Mauro José Lahm Cardoso ◽  
Fabiano Séllos Costa ◽  
Luciane Holsback ◽  
Thais Helena Constantino Patelli ◽  
Maíra Melussi ◽  
...  

The aim of this study is to determine the occurrence of creatine kinase (CK) serum activity in cats with hyperthyroidism and its associations with clinical-pathological alterations and with total (TT4) and free (FT4) thyroxin. CK serum activity was evaluated in 19 cats with spontaneous hyperthyroidism, with TT4 ranging from 34.88-294.98nmol L-1 and FT4 ranging from 2.83-52.9pmol L-1 and also by serum biochemical analysis, including the activity of CK, alanine aminotransferase (ALT), alkaline phosphatase (ALP), aspartate aminotransferase (AST), gamma-glutamyl transferase (GGT), cholesterol and bile acids. The reference value for CK considered in this study was of 110-250U L-1. CK serum activity was evaluated in 19 cats with spontaneous hyperthyroidism, with TT4 ranging from 34.88-294.98nmol L-1 and FT4 ranging from 2.83-52. 9pmol L-1. Its activity CK was elevated in 47.3% of cats (≥250U L-1) and presented statistical difference (P<0.05) between cats with or without cardiac disease. CK presented weak association with all parameters in biochemical analysis. In this study, it was not possible to establish a clear association between hyperthyroidism and the increase of CK. However, it is important to highlight the inclusion of CK activity in the routine examinations for the evaluation of hyperthyroidism and for further studies to be developed.


2020 ◽  
Vol 7 (1) ◽  
pp. e000549
Author(s):  
Robin Daniel Abeles ◽  
Matthew Foxton ◽  
Shahid Khan ◽  
Robert Goldin ◽  
Belinda Smith ◽  
...  

BackgroundAnabolic androgenic steroids (AAS) usage is widespread and increasing. AAS drug-induced liver injury (DILI) is recognised but its clinical course and management is poorly described. We report 2 cases of AAS DILI with associated renal dysfunction, managed successfully with oral corticosteroids.MethodsA comprehensive review identified 50 further cases to characterise the clinical and biochemical course. Causality grading was calculated using the updated Roussel Uclaf Causality Assessment Method (RUCAM) score. Data are presented as median values.ResultsThe most common AAS taken was methyldrostanolone. Patients commonly present with jaundice and pruritus but may exhibit other constitutional symptoms. Patients presented 56 days after starting, and bilirubin peaked 28 days after stopping, AAS. Causality assessment was ‘unlikely’ in 1 (2%), ‘possible’ in 31 (60%) and ‘probable’ in 20 (38%). Peak values were: bilirubin 705 μmol/L, alanine transaminase 125 U/L, aspartate transaminase 71 U/L, alkaline phosphatase 262 U/L, gamma-glutamyl transferase 52 U/L, international normalised ratio 1.1. Liver biopsies showed ‘bland’ canalicular cholestasis. 43% of patients developed kidney injury (peak creatinine 225 μmol/L). Therapies included antipruritics, ursodeoxycholic acid and corticosteroids. No patients died or required liver transplantation.ConclusionsPhysicians are likely to encounter AAS DILI. Causality assessment using the updated RUCAM should be performed but defining indications and proving efficacy for therapies remains challenging.


Biomedicines ◽  
2021 ◽  
Vol 9 (1) ◽  
pp. 76
Author(s):  
Viviana Ostrovsky ◽  
Stephen Malnick ◽  
Shahar Ish-Shalom ◽  
Nadya Ziv Sokolowskaia ◽  
Ady Yosepovich ◽  
...  

Denosumab–Prolia®, Xgeva® (Amgen) is a fully human antibody to the receptor activator of the nuclear factor-K ligand (RANKL). Hepatotoxicity is extremely rare, with only one reported case of immune origin. We present a second case of hepatotoxicity resulting from an immune reaction to denosumab. A 43-year-old female was referred to the Endocrinology, Diabetes & Metabolism Department for treatment of low bone mineral density (BMD) following endocrine therapy with letrozole and lucrin because of breast cancer. She developed premature menopause at the age of 36 years when she underwent a left lumpectomy due to an infiltrating duct carcinoma of the breast (T1 NO MO) and was subsequently started on endocrine therapy. Denosumab was started to prevent osteoporosis. On the third year after starting on denosumab and one month after she received the last injection, she became ill. The routine biochemical analysis showed that the levels of alanine aminotransferase (ALT) and aspartate aminotransferase (AST) rose appreciatively to 10 times the upper limit of normal (ULN). The gamma-glutamyl transferase (GGT) level was elevated slightly to 67 U/L (0–38 U/L). The serum gamma-globulin level was elevated to 1.72 g/dL (0.7–1.6 gr/dl), while the total bilirubin (TB) and serum albumin levels were normal. A liver biopsy revealed a moderate to severe chronic inflammatory infiltrate containing MUM-1 positive plasma cells. In addition, numerous CD-3 positive small T lymphocytes and few CD-20 positive B lymphocytes and eosinophils were seen in the portal tracts. Moderate to severe interface hepatitis, bile duct proliferation and mild portal fibrosis were also identified. The results could be consistent with the diagnosis of drug-induced liver injury (DILI).


Sign in / Sign up

Export Citation Format

Share Document